Comparison of treatment strategies for femoro-popliteal disease: A network meta-analysis.

about

Comparison of treatment strategies for femoro-popliteal disease: A network meta-analysis.

Item

http://www.wikidata.org/entity/Q48247913

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Comparison of treatment strategies for femoro-popliteal disease: A network meta-analysis.

@en

Comparison of treatment strategies for femoro-popliteal disease: A network meta-analysis.

@nl

type

Item

label

Comparison of treatment strategies for femoro-popliteal disease: A network meta-analysis.

@en

Comparison of treatment strategies for femoro-popliteal disease: A network meta-analysis.

@nl

prefLabel

Comparison of treatment strategies for femoro-popliteal disease: A network meta-analysis.

@en

Comparison of treatment strategies for femoro-popliteal disease: A network meta-analysis.

@nl

P1476

Comparison of treatment strategies for femoro-popliteal disease: A network meta-analysis

@en

P2093

Edward Koifman

http://www.w3.org/2001/XMLSchema#string

Kyle Buchanan

http://www.w3.org/2001/XMLSchema#string

Michael J Lipinski

http://www.w3.org/2001/XMLSchema#string

Nelson L Bernardo

http://www.w3.org/2001/XMLSchema#string

Ricardo O Escarcega

http://www.w3.org/2001/XMLSchema#string

Won Yu Kang

http://www.w3.org/2001/XMLSchema#string

P2860

Excimer laser recanalization of femoropopliteal lesions and 1-year patency: results of the CELLO registry.

Low-Dose Paclitaxel-Coated Versus Uncoated Percutaneous Transluminal Balloon Angioplasty for Femoropopliteal Peripheral Artery Disease: One-Year Results of the ILLUMENATE European Randomized Clinical Trial (Randomized Trial of a Novel Paclitaxel-Coa

Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve-month Zilver PTX randomized study results.

Technique optimization of orbital atherectomy in calcified peripheral lesions of the lower extremities: the CONFIRM series, a prospective multicenter registry.

Systematic versus selective stent placement after superficial femoral artery balloon angioplasty: a multicenter prospective randomized study.

Balloon angioplasty versus stenting with nitinol stents in intermediate length superficial femoral artery lesions.

An Update on Methods for Revascularization and Expansion of the TASC Lesion Classification to Include Below-the-Knee Arteries: A Supplement to the Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II): The TASC Steering

Durable Clinical Effectiveness With Paclitaxel-Eluting Stents in the Femoropopliteal Artery: 5-Year Results of the Zilver PTX Randomized Trial

Peripheral artery disease. Part 2: medical and endovascular treatment.

Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial.

P304

1320-1328

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

meta-analysis

P356

10.1002/CCD.27484

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ron Waksman

P577

2018-01-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29332315

http://www.w3.org/2001/XMLSchema#string